Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

DYADIC INTERNATIONAL INC

$0.70 -1.63% NASDAQ: DYAI · 15-min delayed
  • JUPITER, Florida
  • Public · NASDAQ: DYAI
  • 5 employees
$25.9MMarket cap
$3.1MRevenue · FY2025
-$7.4MNet income
5Employees
DYAINASDAQ
2004IPO

About DYADIC INTERNATIONAL INC

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$3.1M
Net income
-$7.4M
Total assets
$9.9M
Market cap
$25.9M
Gross margin
24.9%
Operating margin
-232.8%
Net margin
-238.3%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$3.1M
Cost of revenue
$2.3M
Gross profit
$770.5K
Operating expenses
$8.0M
Operating income
-$7.2M
Net income
-$7.4M
EPS (basic)
$-0.23
EPS (diluted)
$-0.23

Balance sheet

Total assets
$9.9M
Current assets
$9.9M
Total liabilities
$8.7M
Current liabilities
$3.7M
Shareholders’ equity
$1.2M

Cash flow

Operating cash flow
-$5.7M
Investing cash flow
$82.1K
Financing cash flow
$5.0M
Net cash flow
-$655.2K

Statements via Polygon.io (SEC filings)

NASDAQ: DYAI
$0.70 -1.63%

15-minute delayed · data by Polygon.io

Past year

$0.68 $1.30

52-week range

Market cap
$25.9M
EPS (diluted)
$-0.23
Shares outstanding
37.0M
Open
Day range
Prev close
Volume
IPO date
Nov 5, 2004

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

  • Reported a net loss of $7.4M in FY2025.
  • Revenue grew 29% from FY2021 to FY2025.
  • Gross margin of 24.9%, net margin -238.3%.
  • Trading 46% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review DYADIC INTERNATIONAL INC.

Write a review
Newsroom

News about DYADIC INTERNATIONAL INC

News & sentiment via Polygon.io

Explore

Similar companies

Browse all →